Nutritional information for patients taking anti-obesity medications
Newswise — Jaime Almandoz, MD, Associate Professor Department of Endocrinology, Internal Medicine As antiobesity drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) become more widely known and prescribed, they are being touted as breakthrough treatments for chronic overweight and obesity. Anti-obesity medications work by signaling to the brain that we have eaten and… Read More »